A detailed history of Bridgeway Capital Management, LLC transactions in Iridex Corp stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 76,975 shares of IRIX stock, worth $133,166. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,975
Previous 77,100 0.16%
Holding current value
$133,166
Previous $166,000 19.28%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.75 - $2.15 $218 - $268
-125 Reduced 0.16%
76,975 $134,000
Q3 2023

Nov 14, 2023

SELL
$1.33 - $2.54 $301,777 - $576,326
-226,900 Reduced 74.64%
77,100 $195,000
Q2 2023

Aug 14, 2023

SELL
$1.76 - $2.43 $44,000 - $60,750
-25,000 Reduced 7.6%
304,000 $659,000
Q1 2023

May 15, 2023

SELL
$2.0 - $2.46 $30,800 - $37,884
-15,400 Reduced 4.47%
329,000 $667,000
Q2 2022

Aug 15, 2022

BUY
$2.48 - $4.66 $62,000 - $116,500
25,000 Added 7.83%
344,400 $885,000
Q4 2021

Feb 14, 2022

BUY
$5.62 - $9.37 $83,176 - $138,676
14,800 Added 4.86%
319,400 $1.95 Million
Q3 2021

Nov 15, 2021

BUY
$6.29 - $7.98 $254,116 - $322,392
40,400 Added 15.29%
304,600 $2.33 Million
Q2 2021

Aug 16, 2021

BUY
$6.67 - $9.2 $319,493 - $440,679
47,900 Added 22.15%
264,200 $1.87 Million
Q1 2021

May 17, 2021

BUY
$2.18 - $7.71 $163,064 - $576,708
74,800 Added 52.86%
216,300 $1.46 Million
Q4 2020

Feb 16, 2021

BUY
$1.62 - $2.91 $97,200 - $174,600
60,000 Added 73.62%
141,500 $355,000
Q2 2018

Aug 14, 2018

BUY
$5.33 - $7.24 $186,017 - $252,676
34,900 Added 74.89%
81,500 $553,000
Q1 2018

May 15, 2018

SELL
$5.72 - $8.28 $117,260 - $169,740
-20,500 Reduced 30.55%
46,600 $267,000
Q3 2017

Nov 14, 2017

BUY
$8.19 - $10.25 $549,549 - $687,775
67,100
67,100 $629,000

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $27.7M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.